| Reaction Details |
|---|
 | Report a problem with these data |
| Target | 5-hydroxytryptamine receptor 2C |
|---|
| Ligand | BDBM50151982 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_305257 |
|---|
| IC50 | 2000±n/a nM |
|---|
| Citation |  Heinrich, T; Böttcher, H; Gericke, R; Bartoszyk, GD; Anzali, S; Seyfried, CA; Greiner, HE; Van Amsterdam, C Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors. J Med Chem47:4684-92 (2004) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| 5-hydroxytryptamine receptor 2C |
|---|
| Name: | 5-hydroxytryptamine receptor 2C |
|---|
| Synonyms: | 5-HT2C | 5-hydroxytryptamine receptor 2C | 5-hydroxytryptamine receptor 2C (5HT2c) | 5HT2C_RAT | 5ht1c | Htr1c | Htr2c | Serotonin (5-HT) receptor | Serotonin receptor 2a and 2c (5HT2A and 5HT2C) |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 51935.10 |
|---|
| Organism: | Rattus norvegicus (Rat) |
|---|
| Description: | P08909 |
|---|
| Residue: | 460 |
|---|
| Sequence: | MVNLGNAVRSLLMHLIGLLVWQFDISISPVAAIVTDTFNSSDGGRLFQFPDGVQNWPALS
IVVIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYV
WPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVW
AISIGVSVPIPVIGLRDESKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYFLTIY
VLRRQTLMLLRGHTEEELANMSLNFLNCCCKKNGGEEENAPNPNPDQKPRRKKKEKRPRG
TMQAINNEKKASKVLGIVFFVFLIMWCPFFITNILSVLCGKACNQKLMEKLLNVFVWIGY
VCSGINPLVYTLFNKIYRRAFSKYLRCDYKPDKKPPVRQIPRVAATALSGRELNVNIYRH
TNERVARKANDPEPGIEMQVENLELPVNPSNVVSERISSV
|
|
|
|---|
| BDBM50151982 |
|---|
| n/a |
|---|
| Name | BDBM50151982 |
|---|
| Synonyms: | 5-{4-[4-(5-Cyano-1H-indol-3-yl)-butyl]-piperazin-1-yl}-benzofuran-2-carboxylic acid amide | CHEMBL439849 | VILAZODONE |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C26H27N5O2 |
|---|
| Mol. Mass. | 441.5249 |
|---|
| SMILES | NC(=O)c1cc2cc(ccc2o1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1 |
|---|
| Structure | 
|
|---|
Search and Browse
